261 related articles for article (PubMed ID: 14730614)
1. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block.
Clancy RM; Kapur RP; Molad Y; Askanase AD; Buyon JP
Arthritis Rheum; 2004 Jan; 50(1):173-82. PubMed ID: 14730614
[TBL] [Abstract][Full Text] [Related]
2. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
Clancy RM; Buyon JP
Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
[TBL] [Abstract][Full Text] [Related]
3. Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block.
Clancy RM; Zheng P; O'Mahony M; Izmirly P; Zavadil J; Gardner L; Buyon JP
Arthritis Rheum; 2007 Dec; 56(12):4120-31. PubMed ID: 18050204
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune-associated congenital heart block: dissecting the cascade from immunologic insult to relentless fibrosis.
Clancy RM; Buyon JP
Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):1027-35. PubMed ID: 15368347
[TBL] [Abstract][Full Text] [Related]
5. Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block.
Buyon JP; Clancy RM
Lupus; 2008 Feb; 17(2):86-90. PubMed ID: 18250129
[TBL] [Abstract][Full Text] [Related]
6. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block.
Clancy RM; Askanase AD; Kapur RP; Chiopelas E; Azar N; Miranda-Carus ME; Buyon JP
J Immunol; 2002 Aug; 169(4):2156-63. PubMed ID: 12165545
[TBL] [Abstract][Full Text] [Related]
7. Subcellular redistribution of la/SSB autoantigen during physiologic apoptosis in the fetal mouse heart and conduction system: a clue to the pathogenesis of congenital heart block.
Tran HB; Ohlsson M; Beroukas D; Hiscock J; Bradley J; Buyon JP; Gordon TP
Arthritis Rheum; 2002 Jan; 46(1):202-8. PubMed ID: 11817591
[TBL] [Abstract][Full Text] [Related]
8. Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells.
Neufing PJ; Clancy RM; Jackson MW; Tran HB; Buyon JP; Gordon TP
Arthritis Rheum; 2005 Dec; 52(12):3934-42. PubMed ID: 16320341
[TBL] [Abstract][Full Text] [Related]
9. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus.
Tran HB; Macardle PJ; Hiscock J; Cavill D; Bradley J; Buyon JP; Gordon TP
Arthritis Rheum; 2002 Jun; 46(6):1572-9. PubMed ID: 12115188
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody-associated congenital heart block: TGFbeta and the road to scar.
Buyon JP; Clancy RM
Autoimmun Rev; 2005 Jan; 4(1):1-7. PubMed ID: 15652772
[TBL] [Abstract][Full Text] [Related]
11. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
12. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.
Clancy RM; Neufing PJ; Zheng P; O'Mahony M; Nimmerjahn F; Gordon TP; Buyon JP
J Clin Invest; 2006 Sep; 116(9):2413-22. PubMed ID: 16906225
[TBL] [Abstract][Full Text] [Related]
13. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
[TBL] [Abstract][Full Text] [Related]
14. Clearance of apoptotic cells: TGF-beta in the balance between inflammation and fibrosis.
Clancy RM; Buyon JP
J Leukoc Biol; 2003 Dec; 74(6):959-60. PubMed ID: 12960252
[TBL] [Abstract][Full Text] [Related]
15. From antibody insult to fibrosis in neonatal lupus - the heart of the matter.
Buyon JP; Clancy RM
Arthritis Res Ther; 2003; 5(6):266-70. PubMed ID: 14680501
[TBL] [Abstract][Full Text] [Related]
16. Neonatal lupus: basic research and clinical perspectives.
Buyon JP; Clancy RM
Rheum Dis Clin North Am; 2005 May; 31(2):299-313, vii. PubMed ID: 15922147
[TBL] [Abstract][Full Text] [Related]
17. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
[TBL] [Abstract][Full Text] [Related]
18. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
[TBL] [Abstract][Full Text] [Related]
19. Specificity and effector mechanisms of autoantibodies in congenital heart block.
Wahren-Herlenius M; Sonesson SE
Curr Opin Immunol; 2006 Dec; 18(6):690-6. PubMed ID: 17011766
[TBL] [Abstract][Full Text] [Related]
20. Placental and fetal cardiac laminin are targets for cross-reacting autoantibodies from mothers of children with congenital heart block.
Horsfall AC; Li JM; Maini RN
J Autoimmun; 1996 Aug; 9(4):561-8. PubMed ID: 8864833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
